Louis J.M. van der Putten

Added Value of Estrogen Receptor, ProgesteroneReceptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models

Louis J.M. van der Putten, Nicole C.M. Visser, Koen Van de Vijver et al. · International Journal of Gynecological Cancer · 2018 · 61 citations · Full text

Medicine, Oncology, Pathology +14

Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study

Casper Reijnen, Evangelia Gogou, Nicole C.M. Visser et al. · PLoS Medicine · 2020 · 54 citations · Full text

Medicine, Gynecology, Oncology +16

Neoadjuvant Chemotherapy Followed by Surgery for Advanced-Stage Endometrial Cancer

Norbert Lange, N Ezendam, Janice S. Kwon et al. · Current Oncology · 2019 · 50 citations · Full text

Medicine, Oncology, Surgery +17

Molecular profiles of benign and (pre)malignant endometrial lesions

Louis J.M. van der Putten, Renée van Hoof, Bastiaan B.J. Tops et al. · Carcinogenesis · 2017 · 39 citations · Full text

Medicine, Molecular Biology, Pathology +17

Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer

Stephanie Vrede, Willem Jan van Weelden, Nicole C.M. Visser et al. · Gynecologic Oncology · 2021 · 37 citations · Full text

Medicine, Gynecology, Oncology +14